308 related articles for article (PubMed ID: 27876358)
1. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid.
Amagai M; Ikeda S; Hashimoto T; Mizuashi M; Fujisawa A; Ihn H; Matsuzaki Y; Ohtsuka M; Fujiwara H; Furuta J; Tago O; Yamagami J; Tanikawa A; Uhara H; Morita A; Nakanishi G; Tani M; Aoyama Y; Makino E; Muto M; Manabe M; Konno T; Murata S; Izaki S; Watanabe H; Yamaguchi Y; Matsukura S; Seishima M; Habe K; Yoshida Y; Kaneko S; Shindo H; Nakajima K; Kanekura T; Takahashi K; Kitajima Y; Hashimoto K;
J Dermatol Sci; 2017 Feb; 85(2):77-84. PubMed ID: 27876358
[TBL] [Abstract][Full Text] [Related]
2. Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid.
Sami N; Ali S; Bhol KC; Ahmed AR
J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):641-5. PubMed ID: 14761129
[TBL] [Abstract][Full Text] [Related]
3. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of interferon-gamma in patients with refractory bullous pemphigoid.
Nakama T; Ishii N; Ono F; Hamada T; Yasumoto S; Hashimoto T
J Dermatol; 2007 Nov; 34(11):737-45. PubMed ID: 17973812
[TBL] [Abstract][Full Text] [Related]
5. Intravenous IgG Reduces Pathogenic Autoantibodies, Serum IL-6 Levels, and Disease Severity in Experimental Bullous Pemphigoid Models.
Sasaoka T; Ujiie H; Nishie W; Iwata H; Ishikawa M; Higashino H; Natsuga K; Shinkuma S; Shimizu H
J Invest Dermatol; 2018 Jun; 138(6):1260-1267. PubMed ID: 29391250
[TBL] [Abstract][Full Text] [Related]
6. Association between effective dose of prednisolone, alone or in conjunction with other immunosuppressants, and titre of anti-bullous pemphigoid 180 antibody: a retrospective study of 42 cases.
Miida H; Fujiwara H; Ito M
Clin Exp Dermatol; 2011 Jul; 36(5):485-8. PubMed ID: 21392080
[TBL] [Abstract][Full Text] [Related]
7. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.
Fichel F; Barbe C; Joly P; Bedane C; Vabres P; Truchetet F; Aubin F; Michel C; Jegou J; Grange F; Antonicelli F; Bernard P
JAMA Dermatol; 2014 Jan; 150(1):25-33. PubMed ID: 24226428
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of prednisolone and i.v. immunoglobulin treatment decreases circulating interleukin-5 and eosinophils in a patient with bullous pemphigoid.
Yamashita C; Nakamizo S; Honda Y; Dainichi T; Kabashima K
J Dermatol; 2017 Jan; 44(1):101-102. PubMed ID: 27154738
[No Abstract] [Full Text] [Related]
10. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
12. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
[TBL] [Abstract][Full Text] [Related]
13. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
14. Infantile bullous pemphigoid successfully treated with intravenous immunoglobulin therapy.
Watanabe T; Hara S; Muto J; Watanabe D; Akiyama M
Clin Exp Dermatol; 2017 Jul; 42(5):576-578. PubMed ID: 28543802
[No Abstract] [Full Text] [Related]
15. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S
Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167
[TBL] [Abstract][Full Text] [Related]
16. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
[No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in Japan.
Ujiie H; Arakawa M; Aoyama Y
J Dermatol Sci; 2023 Jan; 109(1):22-29. PubMed ID: 36697305
[TBL] [Abstract][Full Text] [Related]
18. Bullous Pemphigoid in Three Paediatric Patients in Finland.
Pankakoski A; Panelius J; Salava A; Kluger N
Acta Derm Venereol; 2020 Mar; 100(6):adv00086. PubMed ID: 32157316
[No Abstract] [Full Text] [Related]
19. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Dec; 45(6):825-35. PubMed ID: 11712025
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
